A phase IV one-arm open-label multicenter study evaluating effect of treatment change to atazanavir/ritonavir on brachial endothelial function of HIV infected patient receiving function in HIV infected patient receiving potent antiretroviral combination therapy.

Trial Profile

A phase IV one-arm open-label multicenter study evaluating effect of treatment change to atazanavir/ritonavir on brachial endothelial function of HIV infected patient receiving function in HIV infected patient receiving potent antiretroviral combination therapy.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2010

At a glance

  • Drugs Atazanavir; Lopinavir; Ritonavir
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Acronyms AMAZONE
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 23 Jun 2008 Status changed from completed to discontinued, as reported by ClinicalTrials.gov.
    • 08 Nov 2007 The expected completion date for this trial is now 1 Apr 2007.
    • 02 Nov 2007 Status change from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top